Pages that link to "Q90329698"
Jump to navigation
Jump to search
The following pages link to Clinical considerations for patients with diabetes in times of COVID-19 epidemic (Q90329698):
Displaying 50 items.
- Diabetes and the COVID-19 Pandemic: How Insights from Recent Experience Might Guide Future Management (Q91756193) (← links)
- COVID-19 and endocrine diseases. A statement from the European Society of Endocrinology (Q91832072) (← links)
- Telemedicine for diabetes care in India during COVID19 pandemic and national lockdown period: Guidelines for physicians (Q91866448) (← links)
- Recommendations for Metabolic and Bariatric Surgery During the COVID-19 Pandemic from IFSO (Q91936633) (← links)
- Diabetes in COVID-19: Prevalence, pathophysiology, prognosis and practical considerations (Q91991326) (← links)
- Artificial Intelligence (AI) applications for COVID-19 pandemic (Q92034760) (← links)
- Diabetic patients with COVID-19 infection are at higher risk of ICU admission and poor short-term outcome (Q92040609) (← links)
- Diabetes self-management amid COVID-19 pandemic (Q92083255) (← links)
- Letter to the editor in response to article: "Clinical considerations for patients with diabetes in times of COVID-19 epidemic (Gupta et al.). (Q93182697) (← links)
- Enhancing immunity in viral infections, with special emphasis on COVID-19: A review (Q93225516) (← links)
- GIS-based spatial modeling of COVID-19 incidence rate in the continental United States (Q93230468) (← links)
- Can pioglitazone be potentially useful therapeutically in treating patients with COVID-19? (Q94447185) (← links)
- Letter to the Editor in Response to article: "Clinical considerations for patients with diabetes in times of COVID-19 epidemic (Gupta et al.)" (Q94447490) (← links)
- Industry 4.0 technologies and their applications in fighting COVID-19 pandemic (Q94447498) (← links)
- Neurosurgical management of brain and spine tumors in the COVID-19 era: an institutional experience from the epicenter of the pandemic (Q94556013) (← links)
- Caring for Pediatric Patients with Diabetes amidst the COVID-19 Storm (Q94588218) (← links)
- COVID-19 and diabetes mellitus: An unholy interaction of two pandemics (Q94863246) (← links)
- Internet of things (IoT) applications to fight against COVID-19 pandemic (Q94863259) (← links)
- Diabetes and COVID-19: evidence, current status and unanswered research questions (Q94671390) (← links)
- Prevention and management of COVID-19 among patients with diabetes: an appraisal of the literature (Q94674310) (← links)
- Is diabetes mellitus associated with mortality and severity of COVID-19? A meta-analysis (Q94680716) (← links)
- Coping with diabetes during the COVID - 19 lockdown in India: Results of an online pilot survey (Q94951721) (← links)
- Mechanism of inflammatory response in associated comorbidities in COVID-19 (Q94954228) (← links)
- Surgical treatment of diabetic foot ulcers during the COVID-19 pandemic in China (Q94959599) (← links)
- The urgent need for integrated science to fight COVID-19 pandemic and beyond (Q95260242) (← links)
- Diabetes and COVID-19 : Disease-Management-People (Q95271851) (← links)
- Significant applications of virtual reality for COVID-19 pandemic (Q95300796) (← links)
- Diabetes and metabolic syndrome as risk factors for COVID-19 (Q95300834) (← links)
- Letter to the editor in response to article: "Clinical considerations for patients with diabetes in times of COVID-19 epidemic (Gupta et al.). (Q95635599) (← links)
- Letter to the editor in response to: Telemedicine for diabetes care in India during COVID19 pandemic and national lockdown period: Guidelines for physicians (Q95652455) (← links)
- Clinical characteristics and chest CT imaging features of critically ill COVID-19 patients (Q96033039) (← links)
- Re:(In) visible impact of inadequate WaSH Provision on COVID-19 incidences can be not be ignored in large and megacities of India (Q96293804) (← links)
- Coronavirus Disease (COVID-19-SARS-CoV-2) and Nutrition: Is Infection in Italy Suggesting a Connection? (Q96647302) (← links)
- Obesity and diabetes as high-risk factors for severe coronavirus disease 2019 (COVID-19) (Q96690341) (← links)
- Impact of nutritional status and anemia on COVID-19: Is it a public health concern? Evidence from National Family Health Survey-4 (2015-2016), India (Q96769327) (← links)
- COVID-19 Impact on People with Diabetes in the South and Central America (Q97084218) (← links)
- A Novel Indicator Predicts 2019 Novel Coronavirus Infection in Subjects with Diabetes (Q97084227) (← links)
- The Impact of COVID-19 on People with Diabetes in Brazil (Q97084257) (← links)
- COVID-19 in people living with diabetes: An international consensus (Q97526525) (← links)
- Wheat and chaffs in the interpretation of the current COVID19 outbreak in Italy (Q97529825) (← links)
- Endocrine and metabolic aspects of the COVID-19 pandemic (Q97546353) (← links)
- Hypoglycemia at the time of Covid-19 pandemic (Q97555181) (← links)
- Association of hypertension, diabetes, stroke, cancer, kidney disease, and high-cholesterol with COVID-19 disease severity and fatality: A systematic review (Q97555572) (← links)
- COVID-19 and hypertension-evidence and practical management: Guidance from the HOPE Asia Network (Q97555961) (← links)
- Vaccine development against coronavirus (2003 to present): An overview, recent advances, current scenario, opportunities and challenges (Q98209615) (← links)
- Caring for children and adolescents with type 1 diabetes mellitus: italian society for pediatric and adolescent diabetes (ISPED) Statements during COVID-19 pandemia (Q98626277) (← links)
- The association of diabetes and the prognosis of COVID-19 patients: a retrospective study (Q98775710) (← links)
- The challenge of diabetes home control in COVID-19 times: proof is in the pudding (Q98775718) (← links)
- The potential similarities of COVID-19 and autoimmune disease pathogenesis and therapeutic options: new insights approach (Q98947637) (← links)
- Possibility of magnesium supplementation for supportive treatment in patients with COVID-19 (Q99547051) (← links)